Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[27] [28] [32] Exenatide was predicted by Amylin scientist Alain Baron to begin undergoing the Food and Drug Administration's approval process in 2004
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 50 print issues and online access 261,46 per year only 5,23 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Padawer J
Evidence for platelet involvement and probucol-sensitive mechanism
Patch testing or careful introduction is reasonable for patients with sensitive skin
Wellner VP et al
US$ 24.08
US$ 22.33
US$ 29.47
US$ 22.57
US$ 24.55
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
US$ 27.84
US$ 22.08
US$ 20.72
US$ 24.07
